Product Details
Lantus SoloStar Insulin Glargine 100 Units/ml Injection 5 x 3 ml Pens In Pakistan
Lantus SoloStar contains insulin glargine 100 Units/ml (U-100), a long-acting insulin analogue used for the treatment of diabetes mellitus. Each prefilled SoloStar pen contains 3 ml of insulin glargine, equivalent to 300 units, and the pack contains 5 disposable prefilled pens. Lantus is designed to provide a prolonged glucose-lowering effect and is administered by subcutaneous injection.
Lantus SoloStar may be prescribed for adults, adolescents and children aged 2 years and above, depending on the patient's individual treatment plan. The insulin dose is determined by a healthcare professional according to blood-glucose levels, diabetes type, other medicines and individual insulin requirements.
Benefits
-
Contains long-acting insulin glargine 100 Units/ml.
-
Provides prolonged blood-glucose-lowering action.
-
Convenient prefilled SoloStar pen format.
-
Each 3 ml pen contains 300 units of insulin.
-
Suitable for prescribed diabetes management in eligible patients.
-
Designed for subcutaneous administration.
-
Pack contains 5 prefilled disposable pens.
-
Can be incorporated into an individualized diabetes treatment plan under medical supervision.
Specifications
| Specification | Details |
|---|---|
| Brand | Lantus SoloStar |
| Active Ingredient | Insulin Glargine |
| Strength | 100 Units/ml (U-100) |
| Dosage Form | Solution for Injection |
| Pen Volume | 3 ml |
| Insulin per Pen | 300 Units |
| Pack Size | 5 × 3 ml Prefilled Pens |
| Administration | Subcutaneous |
| Drug Class | Long-acting insulin analogue |
| Manufacturer/Brand | Sanofi |
| Intended Use | Diabetes mellitus management |
| Storage | Follow the product packaging and pharmacist/doctor's storage instructions |
How To Use
Lantus SoloStar should be used only according to the prescription and instructions provided by your doctor or diabetes healthcare professional. Lantus is generally administered subcutaneously once daily at the same time each day, but the exact dose and treatment schedule must be individualized.
Before using the pen, check the product and follow the official SoloStar instructions supplied with the medicine. Use a new suitable needle for each injection and rotate injection sites as advised by your healthcare professional to reduce the risk of injection-site problems.
Important: Lantus should not be administered intravenously, mixed with another insulin, or diluted. Do not change your insulin dose or switch insulin products without medical advice.
The SoloStar pen is intended for single-patient use and must never be shared with another person, even if the needle has been changed.
Why Choose Lantus SoloStar?
Lantus SoloStar combines insulin glargine 100 Units/ml with a convenient prefilled pen design. Each pen contains 3 ml of solution and provides 300 units of insulin, while the 5-pen pack can be useful for patients whose prescribed treatment requires regular insulin administration.
Lantus is an established long-acting insulin product from Sanofi and is intended to be used as part of an individualized diabetes-management plan under professional medical supervision.
